Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/BCX4430> ?p ?o }
Showing triples 1 to 86 of
86
with 100 triples per page.
- BCX4430 abstract "BCX4430 (Immucillin-A) is an antiviral drug, an adenosine analog (a type of nucleoside analog). It is developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. It also shows broad-spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses. BCX4430 has been demonstrated to protect against both Ebola and Marburg viruses in both rodents and monkeys, even when administered up to 48 hours after infection, and development for use in humans is being fast-tracked due to concerns about the lack of treatment options for the ongoing Ebola virus epidemic in West Africa.".
- BCX4430 casNumber "222631-44-9".
- BCX4430 fdaUniiCode "OLF97F86A7".
- BCX4430 iupacName "(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol".
- BCX4430 pubchem "69211190".
- BCX4430 thumbnail BCX4430.svg?width=300.
- BCX4430 wikiPageID "44026454".
- BCX4430 wikiPageLength "3786".
- BCX4430 wikiPageOutDegree "29".
- BCX4430 wikiPageRevisionID "678516109".
- BCX4430 wikiPageWikiLink 3-Deazaneplanocin_A.
- BCX4430 wikiPageWikiLink Adenosine.
- BCX4430 wikiPageWikiLink Antiviral_drug.
- BCX4430 wikiPageWikiLink Arenavirus.
- BCX4430 wikiPageWikiLink BioCryst_Pharmaceuticals.
- BCX4430 wikiPageWikiLink Brincidofovir.
- BCX4430 wikiPageWikiLink Bunyaviridae.
- BCX4430 wikiPageWikiLink Category:Anti-RNA_virus_drugs.
- BCX4430 wikiPageWikiLink Category:Antivirals.
- BCX4430 wikiPageWikiLink Category:Ebola.
- BCX4430 wikiPageWikiLink Category:Nucleosides.
- BCX4430 wikiPageWikiLink Coronavirus.
- BCX4430 wikiPageWikiLink Ebola_virus_disease.
- BCX4430 wikiPageWikiLink FGI-106.
- BCX4430 wikiPageWikiLink Favipiravir.
- BCX4430 wikiPageWikiLink Filoviridae.
- BCX4430 wikiPageWikiLink Flavivirus.
- BCX4430 wikiPageWikiLink Hepatitis_C.
- BCX4430 wikiPageWikiLink JK-05.
- BCX4430 wikiPageWikiLink Lamivudine.
- BCX4430 wikiPageWikiLink Marburg_virus_disease.
- BCX4430 wikiPageWikiLink National_Institute_of_Allergy_and_Infectious_Diseases.
- BCX4430 wikiPageWikiLink Nucleoside_analogue.
- BCX4430 wikiPageWikiLink Paramyxoviridae.
- BCX4430 wikiPageWikiLink Ribavirin.
- BCX4430 wikiPageWikiLink TKM-Ebola.
- BCX4430 wikiPageWikiLink Triazavirin.
- BCX4430 wikiPageWikiLink West_African_Ebola_virus_epidemic.
- BCX4430 wikiPageWikiLink ZMapp.
- BCX4430 wikiPageWikiLinkText "BCX4430".
- BCX4430 c "11".
- BCX4430 casNumber "222631".
- BCX4430 chemspiderid "8620968".
- BCX4430 h "15".
- BCX4430 inchi "1".
- BCX4430 inchikey "AMFDITJFBUXZQN-KUBHLMPHBQ".
- BCX4430 iupacName "-2".
- BCX4430 legalStatus "Investigational New Drug".
- BCX4430 molecularWeight "265.268".
- BCX4430 n "5".
- BCX4430 o "3".
- BCX4430 pubchem "69211190".
- BCX4430 smiles "O[C@H]3[C@H]N[C@H][C@H]3O".
- BCX4430 stdinchi "1".
- BCX4430 stdinchikey "AMFDITJFBUXZQN-KUBHLMPHSA-N".
- BCX4430 unii "OLF97F86A7".
- BCX4430 wikiPageUsesTemplate Template:Cascite.
- BCX4430 wikiPageUsesTemplate Template:Drugbankcite.
- BCX4430 wikiPageUsesTemplate Template:Drugbox.
- BCX4430 wikiPageUsesTemplate Template:Ebola.
- BCX4430 wikiPageUsesTemplate Template:Fdacite.
- BCX4430 wikiPageUsesTemplate Template:Pharm-stub.
- BCX4430 wikiPageUsesTemplate Template:RNA_antivirals.
- BCX4430 wikiPageUsesTemplate Template:Reflist.
- BCX4430 subject Category:Anti-RNA_virus_drugs.
- BCX4430 subject Category:Antivirals.
- BCX4430 subject Category:Ebola.
- BCX4430 subject Category:Nucleosides.
- BCX4430 hypernym Drug.
- BCX4430 type ChemicalSubstance.
- BCX4430 type Drug.
- BCX4430 type ChemicalObject.
- BCX4430 type Thing.
- BCX4430 type Q8386.
- BCX4430 comment "BCX4430 (Immucillin-A) is an antiviral drug, an adenosine analog (a type of nucleoside analog). It is developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease.".
- BCX4430 label "BCX4430".
- BCX4430 sameAs Q18209997.
- BCX4430 sameAs BCX4430.
- BCX4430 sameAs BCX4430.
- BCX4430 sameAs BCX4430.
- BCX4430 sameAs BCX4430.
- BCX4430 sameAs m.0121l4tk.
- BCX4430 sameAs Q18209997.
- BCX4430 wasDerivedFrom BCX4430?oldid=678516109.
- BCX4430 depiction BCX4430.svg.
- BCX4430 isPrimaryTopicOf BCX4430.